« Previous
Next »
Transplantation Proceedings
Volume 42, Issue 6
, Pages 2006-2008
, July 2010
Alemtuzumab with Rapid Steroid Taper in Simultaneous Kidney and Pancreas Transplantation: Comparison to Induction with Antithymocyte Globulin
References
- . Pancreas transplantation. Lancet. 2009;373:1808
- Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. Transplant Proc. 2006;38:1307
- Alemtuzumab induction and tacrolimus montherapy in pancreas transplantation: one- and two-year outcomes. Transplantation. 2006;82:1621
- . Alemtuzumab induction and prednisone-free maintatinance immunotherapy in simultaneous pancreas-kidney transplantation: comparison with rabbit antithymocyte globulin—long-term results. Am J Transplant. 2006;6:331
- A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. Am J Transplant. 2008;8:1702
- Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation. 2009;87:125
- Alemtuzumab induction and steroid-free maintainance immunosuppression in pancreas transplantation. Am J Transplant. 2008;8:2126
- . Subcutaneous administration of alemtuzumab in pancreas-kidney transplantation. Transplantation. 2007;84:1563
- Calcineurin inhibitor– and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation. 2005;79:1184
PII: S0041-1345(10)00755-4
doi: 10.1016/j.transproceed.2010.05.090
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Transplantation Proceedings
Volume 42, Issue 6
, Pages 2006-2008
, July 2010
